Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ROBERT ATMAR and MARY ESTES.
ROBERT ATMAR
Connection Strength
13.944
MARY ESTES
  1. GI.1 Norovirus Neutralizing Antibody Levels Are Correlated with GI.1 Histo-blood Group Antigen-Blocking Antibody Levels. J Infect Dis. 2024 Jun 12.
    View in: PubMed
    Score: 0.969
  2. A Bivalent Human Norovirus Vaccine Induces Homotypic and Heterotypic Neutralizing Antibodies. J Infect Dis. 2024 May 15; 229(5):1402-1407.
    View in: PubMed
    Score: 0.964
  3. Comparison of Microneutralization and Histo-Blood Group Antigen-Blocking Assays for Functional Norovirus Antibody Detection. J Infect Dis. 2020 02 18; 221(5):739-743.
    View in: PubMed
    Score: 0.718
  4. Human Norovirus Cultivation in Nontransformed Stem Cell-Derived Human Intestinal Enteroid Cultures: Success and Challenges. Viruses. 2019 07 11; 11(7).
    View in: PubMed
    Score: 0.689
  5. Human noroviruses: recent advances in a 50-year history. Curr Opin Infect Dis. 2018 10; 31(5):422-432.
    View in: PubMed
    Score: 0.653
  6. Noroviruses everywhere: has something changed? Curr Opin Infect Dis. 2006 Oct; 19(5):467-74.
    View in: PubMed
    Score: 0.284
  7. The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am. 2006 Jun; 35(2):275-90, viii.
    View in: PubMed
    Score: 0.278
  8. Lack of Detection of Norwalk Virus in Saliva Samples From a Controlled Human Infection Model. Open Forum Infect Dis. 2024 Nov; 11(11):ofae652.
    View in: PubMed
    Score: 0.249
  9. Insights into human norovirus cultivation in human intestinal enteroids. mSphere. 2024 Nov 21; 9(11):e0044824.
    View in: PubMed
    Score: 0.248
  10. INTRA- AND INTER-HOST EVOLUTION OF HUMAN NOROVIRUS IN HEALTHY ADULTS. bioRxiv. 2024 Sep 05.
    View in: PubMed
    Score: 0.246
  11. Bile acid-sensitive human norovirus strains are susceptible to sphingosine-1-phosphate receptor 2 inhibition. J Virol. 2024 Jul 23; 98(7):e0202023.
    View in: PubMed
    Score: 0.242
  12. Bile acid-sensitive human norovirus strains are susceptible to sphingosine-1-phosphate receptor 2 inhibition. bioRxiv. 2024 Jan 03.
    View in: PubMed
    Score: 0.235
  13. Standardization of an antiviral pipeline for human norovirus in human intestinal enteroids demonstrates nitazoxanide has no to weak antiviral activity. Antimicrob Agents Chemother. 2023 10 18; 67(10):e0063623.
    View in: PubMed
    Score: 0.231
  14. A Standardized Antiviral Pipeline for Human Norovirus in Human Intestinal Enteroids Demonstrates No Antiviral Activity of Nitazoxanide. bioRxiv. 2023 May 23.
    View in: PubMed
    Score: 0.225
  15. CLIC and membrane wound repair pathways enable pandemic norovirus entry and infection. Nat Commun. 2023 02 28; 14(1):1148.
    View in: PubMed
    Score: 0.222
  16. Antiviral Activity of Olanexidine-Containing Hand Rub against Human Noroviruses. mBio. 2022 04 26; 13(2):e0284821.
    View in: PubMed
    Score: 0.207
  17. Bile Goes Viral. Viruses. 2021 05 27; 13(6).
    View in: PubMed
    Score: 0.196
  18. New Insights and Enhanced Human Norovirus Cultivation in Human Intestinal Enteroids. mSphere. 2021 01 27; 6(1).
    View in: PubMed
    Score: 0.192
  19. Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses. Clin Microbiol Rev. 2001 Jan; 14(1):15-37.
    View in: PubMed
    Score: 0.191
  20. Human norovirus exhibits strain-specific sensitivity to host interferon pathways in human intestinal enteroids. Proc Natl Acad Sci U S A. 2020 09 22; 117(38):23782-23793.
    View in: PubMed
    Score: 0.187
  21. Bile acids and ceramide overcome the entry restriction for GII.3 human norovirus replication in human intestinal enteroids. Proc Natl Acad Sci U S A. 2020 01 21; 117(3):1700-1710.
    View in: PubMed
    Score: 0.178
  22. Nonculturable agents of viral gastroenteritis. Clin Microbiol Newsl. 1997 Dec 01; 19(23):177-182.
    View in: PubMed
    Score: 0.154
  23. Prospects and Challenges in the Development of a Norovirus Vaccine. Clin Ther. 2017 Aug; 39(8):1537-1549.
    View in: PubMed
    Score: 0.150
  24. B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine. Clin Vaccine Immunol. 2017 May; 24(5).
    View in: PubMed
    Score: 0.148
  25. Replication of Human Norovirus RNA in Mammalian Cells Reveals Lack of Interferon Response. J Virol. 2016 10 01; 90(19):8906-23.
    View in: PubMed
    Score: 0.142
  26. Replication of human noroviruses in stem cell-derived human enteroids. Science. 2016 09 23; 353(6306):1387-1393.
    View in: PubMed
    Score: 0.141
  27. Correction for Hesse et al., Serological Responses to a Norovirus Nonstructural Fusion Protein after Vaccination and Infection. Clin Vaccine Immunol. 2016 08; 23(8):735.
    View in: PubMed
    Score: 0.141
  28. Antiviral targets of human noroviruses. Curr Opin Virol. 2016 06; 18:117-25.
    View in: PubMed
    Score: 0.139
  29. Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go? PLoS Pathog. 2016 04; 12(4):e1005334.
    View in: PubMed
    Score: 0.138
  30. Collaborative evaluation of a method for the detection of Norwalk virus in shellfish tissues by PCR. Appl Environ Microbiol. 1996 Jan; 62(1):254-8.
    View in: PubMed
    Score: 0.135
  31. Serological Responses to a Norovirus Nonstructural Fusion Protein after Vaccination and Infection. Clin Vaccine Immunol. 2016 02; 23(2):181-3.
    View in: PubMed
    Score: 0.134
  32. Norovirus Antigen Detection with a Combination of Monoclonal and Single-Chain Antibodies. J Clin Microbiol. 2015 Dec; 53(12):3916-8.
    View in: PubMed
    Score: 0.133
  33. Detection of Norwalk virus and hepatitis A virus in shellfish tissues with the PCR. Appl Environ Microbiol. 1995 Aug; 61(8):3014-8.
    View in: PubMed
    Score: 0.131
  34. Serological Correlates of Protection against a GII.4 Norovirus. Clin Vaccine Immunol. 2015 Aug; 22(8):923-9.
    View in: PubMed
    Score: 0.130
  35. Mucosal and Cellular Immune Responses to Norwalk Virus. J Infect Dis. 2015 Aug 01; 212(3):397-405.
    View in: PubMed
    Score: 0.127
  36. Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity. Clin Vaccine Immunol. 2015 Feb; 22(2):221-8.
    View in: PubMed
    Score: 0.126
  37. Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies. Clin Vaccine Immunol. 2015 Feb; 22(2):168-77.
    View in: PubMed
    Score: 0.125
  38. Plasmid-based human norovirus reverse genetics system produces reporter-tagged progeny virus containing infectious genomic RNA. Proc Natl Acad Sci U S A. 2014 Sep 23; 111(38):E4043-52.
    View in: PubMed
    Score: 0.123
  39. Structural basis of glycan interaction in gastroenteric viral pathogens. Curr Opin Virol. 2014 Aug; 7:119-27.
    View in: PubMed
    Score: 0.122
  40. Reply to Kirby et al. J Infect Dis. 2015 Jan 01; 211(1):167.
    View in: PubMed
    Score: 0.122
  41. Development of a Gaussia luciferase-based human norovirus protease reporter system: cell type-specific profile of Norwalk virus protease precursors and evaluation of inhibitors. J Virol. 2014 Sep; 88(18):10312-26.
    View in: PubMed
    Score: 0.122
  42. Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol. 2014 Jan; 30(1):25-33.
    View in: PubMed
    Score: 0.117
  43. Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis. 2014 Apr 01; 209(7):1016-22.
    View in: PubMed
    Score: 0.116
  44. Detection of enteric viruses in oysters by using the polymerase chain reaction. Appl Environ Microbiol. 1993 Feb; 59(2):631-5.
    View in: PubMed
    Score: 0.110
  45. Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virus. Clin Vaccine Immunol. 2012 Dec; 19(12):1980-3.
    View in: PubMed
    Score: 0.108
  46. Secretory pathway antagonism by calicivirus homologues of Norwalk virus nonstructural protein p22 is restricted to noroviruses. Virol J. 2012 Sep 03; 9:181.
    View in: PubMed
    Score: 0.107
  47. Noroviruses: The Most Common Pediatric Viral Enteric Pathogen at a Large University Hospital After Introduction of Rotavirus Vaccination. J Pediatric Infect Dis Soc. 2013 Mar; 2(1):57-60.
    View in: PubMed
    Score: 0.106
  48. Stem cell-derived human intestinal organoids as an infection model for rotaviruses. mBio. 2012; 3(4):e00159-12.
    View in: PubMed
    Score: 0.106
  49. Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus. Clin Vaccine Immunol. 2012 Feb; 19(2):284-7.
    View in: PubMed
    Score: 0.102
  50. Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med. 2011 Dec 08; 365(23):2178-87.
    View in: PubMed
    Score: 0.102
  51. Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay. Clin Vaccine Immunol. 2011 Jul; 18(7):1187-90.
    View in: PubMed
    Score: 0.098
  52. Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis. 2010 Oct 15; 202(8):1212-8.
    View in: PubMed
    Score: 0.094
  53. Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans. Virology. 2010 Oct 10; 406(1):1-11.
    View in: PubMed
    Score: 0.093
  54. Norwalk virus shedding after experimental human infection. Emerg Infect Dis. 2008 Oct; 14(10):1553-7.
    View in: PubMed
    Score: 0.082
  55. Norwalk virus RNA is infectious in mammalian cells. J Virol. 2007 Nov; 81(22):12238-48.
    View in: PubMed
    Score: 0.076
  56. Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol. 2005 Sep; 77(1):116-20.
    View in: PubMed
    Score: 0.066
  57. Replication and packaging of Norwalk virus RNA in cultured mammalian cells. Proc Natl Acad Sci U S A. 2005 Jul 19; 102(29):10327-32.
    View in: PubMed
    Score: 0.065
  58. Insights into Human Norovirus Cultivation in Human Intestinal Enteroids. bioRxiv. 2024 Sep 19.
    View in: PubMed
    Score: 0.062
  59. Complete Genomic Characterization of Global Pathogens, Respiratory Syncytial Virus (RSV), and Human Norovirus (HuNoV) Using Probe-based Capture Enrichment. bioRxiv. 2024 Sep 16.
    View in: PubMed
    Score: 0.062
  60. Divergent responses of human intestinal organoid monolayers using commercial in vitro cytotoxicity assays. PLoS One. 2024; 19(6):e0304526.
    View in: PubMed
    Score: 0.061
  61. Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol. 2004 Jun; 12(6):279-87.
    View in: PubMed
    Score: 0.060
  62. 2'-Fucosyllactose Inhibits Human Norovirus Replication in Human Intestinal Enteroids. bioRxiv. 2024 May 30.
    View in: PubMed
    Score: 0.060
  63. N-glycoproteomic analyses of human intestinal enteroids, varying in histo-blood group geno- and phenotypes, reveal a wide repertoire of fucosylated glycoproteins. Glycobiology. 2024 04 24; 34(6).
    View in: PubMed
    Score: 0.060
  64. Laboratory efforts to cultivate noroviruses. J Gen Virol. 2004 Jan; 85(Pt 1):79-87.
    View in: PubMed
    Score: 0.059
  65. A single nanobody neutralizes multiple epochally evolving human noroviruses by modulating capsid plasticity. Nat Commun. 2023 10 16; 14(1):6516.
    View in: PubMed
    Score: 0.058
  66. Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response. NPJ Vaccines. 2023 Jun 06; 8(1):87.
    View in: PubMed
    Score: 0.056
  67. Human Sapovirus Replication in Human Intestinal Enteroids. J Virol. 2023 04 27; 97(4):e0038323.
    View in: PubMed
    Score: 0.056
  68. Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol. 2003 Jan; 77(1):405-15.
    View in: PubMed
    Score: 0.055
  69. Use of Human Intestinal Enteroids to Evaluate Persistence of Infectious Human Norovirus in Seawater. Emerg Infect Dis. 2022 07; 28(7):1475-1479.
    View in: PubMed
    Score: 0.053
  70. Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis. 2002 May 01; 185(9):1335-7.
    View in: PubMed
    Score: 0.052
  71. Atomic structure of the predominant GII.4 human norovirus capsid reveals novel stability and plasticity. Nat Commun. 2022 03 10; 13(1):1241.
    View in: PubMed
    Score: 0.052
  72. Norovirus Protease Structure and Antivirals Development. Viruses. 2021 10 14; 13(10).
    View in: PubMed
    Score: 0.050
  73. Glycan Recognition in Human Norovirus Infections. Viruses. 2021 10 14; 13(10).
    View in: PubMed
    Score: 0.050
  74. Norovirus in Cancer Patients: A Review. Open Forum Infect Dis. 2021 Jun; 8(6):ofab126.
    View in: PubMed
    Score: 0.048
  75. Development of a reverse transcription-PCR-DNA enzyme immunoassay for detection of "Norwalk-like" viruses and hepatitis A virus in stool and shellfish. Appl Environ Microbiol. 2001 Feb; 67(2):742-9.
    View in: PubMed
    Score: 0.048
  76. High-Resolution Mapping of Human Norovirus Antigens via Genomic Phage Display Library Selections and Deep Sequencing. J Virol. 2020 12 09; 95(1).
    View in: PubMed
    Score: 0.047
  77. Development of an immunomagnetic capture reverse transcription-PCR assay for the detection of Norwalk virus. J Virol Methods. 2000 Oct; 90(1):69-78.
    View in: PubMed
    Score: 0.047
  78. Histo-blood group antigens of glycosphingolipids predict susceptibility of human intestinal enteroids to norovirus infection. J Biol Chem. 2020 11 20; 295(47):15974-15987.
    View in: PubMed
    Score: 0.047
  79. Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection. mBio. 2020 03 17; 11(2).
    View in: PubMed
    Score: 0.045
  80. Development of methods to detect "Norwalk-like viruses" (NLVs) and hepatitis A virus in delicatessen foods: application to a food-borne NLV outbreak. Appl Environ Microbiol. 2000 Jan; 66(1):213-8.
    View in: PubMed
    Score: 0.044
  81. Distribution of Norwalk virus within shellfish following bioaccumulation and subsequent depuration by detection using RT-PCR. J Food Prot. 1998 Dec; 61(12):1674-80.
    View in: PubMed
    Score: 0.041
  82. Human Monoclonal Antibodies That Neutralize Pandemic GII.4?Noroviruses. Gastroenterology. 2018 12; 155(6):1898-1907.
    View in: PubMed
    Score: 0.041
  83. Human Norovirus Replication in Human Intestinal Enteroids as Model to Evaluate Virus Inactivation. Emerg Infect Dis. 2018 08; 24(8):1453-1464.
    View in: PubMed
    Score: 0.040
  84. Glycan recognition in globally dominant human rotaviruses. Nat Commun. 2018 07 06; 9(1):2631.
    View in: PubMed
    Score: 0.040
  85. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice. J Virol. 1998 Feb; 72(2):1345-53.
    View in: PubMed
    Score: 0.039
  86. Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades. J Virol. 2017 07 15; 91(14).
    View in: PubMed
    Score: 0.037
  87. Structural features of glycan recognition among viral pathogens. Curr Opin Struct Biol. 2017 06; 44:211-218.
    View in: PubMed
    Score: 0.037
  88. Use of heat release and an internal RNA standard control in reverse transcription-PCR detection of Norwalk virus from stool samples. J Clin Microbiol. 1997 Feb; 35(2):511-4.
    View in: PubMed
    Score: 0.036
  89. Identification and Characterization of Single-Chain Antibodies that Specifically Bind GI Noroviruses. PLoS One. 2017; 12(1):e0170162.
    View in: PubMed
    Score: 0.036
  90. Deep sequencing of phage-displayed peptide libraries reveals sequence motif that detects norovirus. Protein Eng Des Sel. 2017 Feb; 30(2):129-139.
    View in: PubMed
    Score: 0.036
  91. Detection and analysis of a small round-structured virus strain in oysters implicated in an outbreak of acute gastroenteritis. Appl Environ Microbiol. 1996 Nov; 62(11):4268-72.
    View in: PubMed
    Score: 0.036
  92. Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody. Proc Natl Acad Sci U S A. 2016 10 04; 113(40):E5830-E5837.
    View in: PubMed
    Score: 0.035
  93. Detection of human norovirus in intestinal biopsies from immunocompromised transplant patients. J Gen Virol. 2016 09; 97(9):2291-2300.
    View in: PubMed
    Score: 0.035
  94. Frequent Use of the IgA Isotype in Human B Cells Encoding Potent Norovirus-Specific Monoclonal Antibodies That Block HBGA Binding. PLoS Pathog. 2016 06; 12(6):e1005719.
    View in: PubMed
    Score: 0.035
  95. Evaluation of a degenerate primer for the PCR detection of human caliciviruses. Arch Virol. 1996; 141(11):2225-35.
    View in: PubMed
    Score: 0.034
  96. Sensitive detection of norovirus using phage nanoparticle reporters in lateral-flow assay. PLoS One. 2015; 10(5):e0126571.
    View in: PubMed
    Score: 0.032
  97. Noroviruses as a Cause of Diarrhea in Immunocompromised Pediatric Hematopoietic Stem Cell and Solid Organ Transplant Recipients. Am J Transplant. 2015 Jul; 15(7):1874-81.
    View in: PubMed
    Score: 0.032
  98. Characterization of cross-reactive norovirus-specific monoclonal antibodies. Clin Vaccine Immunol. 2015 Feb; 22(2):160-7.
    View in: PubMed
    Score: 0.031
  99. Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. J Infect Dis. 2015 Mar 15; 211(6):870-8.
    View in: PubMed
    Score: 0.031
  100. Identification of human single-chain antibodies with broad reactivity for noroviruses. Protein Eng Des Sel. 2014 Oct; 27(10):339-49.
    View in: PubMed
    Score: 0.030
  101. Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses. J Virol. 2014 Jun; 88(11):6168-80.
    View in: PubMed
    Score: 0.030
  102. Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med. 2014 Jan-Feb; 21(1):6-11.
    View in: PubMed
    Score: 0.029
  103. Identification and characterization of a peptide affinity reagent for detection of noroviruses in clinical samples. J Clin Microbiol. 2013 Jun; 51(6):1803-8.
    View in: PubMed
    Score: 0.028
  104. Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg Infect Dis. 2013 Mar; 19(3):431-8.
    View in: PubMed
    Score: 0.028
  105. Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol. 2011 Sep; 85(17):8635-45.
    View in: PubMed
    Score: 0.025
  106. Norwalk virus-specific binding to oyster digestive tissues. Emerg Infect Dis. 2006 Jun; 12(6):931-6.
    View in: PubMed
    Score: 0.017
  107. In situ detection of hepatitis A virus in cell cultures and shellfish tissues. Appl Environ Microbiol. 1994 Jun; 60(6):1921-6.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.